News
JenaValve Technology, Inc., developer and manufacturer of the Trilogyâ„¢ Transcatheter Heart Valve (THV) System, today announced that patient enrollment has begun in the ARTIST study, an RCT evaluating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results